Glycemic and Cardiometabolic Biomarker improvements associated with reduction in air pollution exposure

Go Back to All Clinical Trials

Glycemic and Cardiometabolic Biomarker improvements associated with reduction in air pollution exposure

Brief description of study

In this research, we will conduct a double-blind, sham-controlled, randomized trial to examine the glycemic and cardiometabolic impact of air pollution exposure reduction using home portable air cleaners (PACs) in a cohort of 142 adult with prediabetes. This study will not evaluate the PAC or sham as medical devices in the context of this research; rather, the PAC and sham will be used per their commercialized indication as tools to standardize the conditions in order to measure the glycemic and cardiometabolic impact of reduced air pollution exposure.

Clinical Study Identifier: s23-00755

ClinicalTrials.gov Identifier: NCT05994937

Principal Investigator: Jonathan Newman.

Other Investigators: Terry Gordon, Jose O. Aleman, Lorna E. Thorpe, Sharine Lynn Wittkopp, William L Blau.

Contact the research team to learn more about this study.

Your Email

Not a valid e-mail address

Please Provide Email Address

First Name

First name is mandatory

Last Name

Your Phone

Please provide phone number

Invalid phone number

Valid phone number

Comments

Send Confirmation of This To Me

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Clinical Research Studies